Zobrazeno 1 - 10 of 64 pro vyhledávání: '"Votan B"'
1
Akademický článek
Patient involvement in research within the Gynecological Cancer InterGroup: A call to action for a systematic approach: Results from a survey.
Autor: Nohová I; Department of Gynaecology, Obstetrics and Neonatology First Faculty of Medicine Charles University and General University Hospital in Prague, Central and Eastern European Gynecologic Oncology Group (CEEGOG) Prague Czech Republic., Andrews J; Australia New Zealand Gynaecological Oncology Group (ANZGOG) Camperdown Australia., Votan B; Association de Recherche dans les CAncers Gynécologiques-Groupe d'Investigateurs National pour l'Etude des Cancers de l'Ovaire et du sein (ARCAGY-GINECO) Paris France., Miller A; Department of Biostatistics and Bioinformatics Roswell Park Comprehensive Cancer Center, GOG Foundation Buffalo New York USA., Sehouli J; Department of Gynecology with Center for Oncological Surgery Charité - Universitätsmedizin Berlin, Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie (NOGGO e.V.) Berlin Germany., Berger R; Department for Gynecology and Obstetrics, Medical University of Innsbruck Arbeitsgemeinschaft Gynäkologische Onkologie Österreich (AGO Austria) Innsbruck Austria.
Publikováno v: Health science reports [Health Sci Rep] 2023 Dec 01; Vol. 6 (12), pp. e1735. Date of Electronic Publication: 2023 Dec 01 (Print Publication: 2023).
Zobrazit plný text záznamu
2
Akademický článek
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup.
Autor: Vergote I; Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Leuven, Belgium; University Hospitals Leuven, Leuven, Belgium. Electronic address: ignace.vergote@uzleuven.be., Gonzalez-Martin A; Grupo Español de Cáncer de Ovario (GEICO), Madrid, Spain; Clinica Universidad de Navarra, Madrid, Spain; Program for Solid Tumors at Madrid, and Center for Applied Medical Research (CIMA), Universidad de Navarra, Pamplona, Spain., Lorusso D; Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO), Naples, Italy; Fondazione Policlinico Gemelli IRCCS, Rome, Italy., Gourley C; Scottish Gynaecological Cancer Trials Group (SGCTG), Cancer Research UK, Edinburgh, UK; Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK., Mirza MR; Nordic Society of Gynecologic Oncology Clinical Trial Unit (NSGO-CTU), Copenhagen, Denmark; Rigshospitalet, Copenhagen, Denmark., Kurtz JE; Groupe d'Investigateurs National des Etudes des Cancers Ovariens et du Sein (GINECO), Paris, France; Strasbourg Cancer Institute, Strasbourg, France., Okamoto A; Japanese Gynecologic Oncology Group (JGOG), Tokyo, Japan; The Jikei University School of Medicine, Tokyo, Japan., Moore K; Gynecologic Oncology Group-Foundation (GOG-F), Philadelphia, PA, USA; OU Health Stephenson Cancer Center, Oklahoma City, OH, USA., Kridelka F; Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Leuven, Belgium; Centre Hospitalier Universitaire de Liège, Liège, Belgium., McNeish I; National Cancer Research Institute (NCRI), London, UK; Department of Surgery and Cancer, Imperial College London, London, UK., Reuss A; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Study Group, Munich, Germany; Coordinating Center for Clinical Trials, Philipps University, Marburg, Germany., Votan B; Association de Recherche Cancers Gynécologiques (ARCAGY)-GINECO, Paris, France., du Bois A; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Study Group, Munich, Germany; Kliniken Essen Mitte (KEM), Essen, Germany., Mahner S; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Study Group, Munich, Germany; University Hospital, Ludwig Maximilians University, Munich, Germany., Ray-Coquard I; Groupe d'Investigateurs National des Etudes des Cancers Ovariens et du Sein (GINECO), Paris, France; Centre Leon Berard and University Claude Bernard Lyon I, Lyon, France., Kohn EC; National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Berek JS; Women's Cancer Research Network-Cooperative Gynecologic Oncology Investigators (WCRN-COGI), Fresno, CA; Stanford Cancer Institute, Stanford, CA, USA., Tan DSP; Asia Pacific Gynecologic Oncology Trials Group (APGOT), Seoul, South Korea; Gynecologic Cancer Group Singapore (GCGS), Singapore; Cancer Science Institute, National University of Singapore, Singapore., Colombo N; Mario Negri Gynecologic Oncology (MaNGO), Milan, Italy; European Institute of Oncology, Milan, Italy; University of Milano-Bicocca, Milan, Italy., Zang R; Shanghai Gynecologic Oncology Group (SGOG), Shanghai, China; Zhongshan Hospital, Fudan University, Shanghai, China., Concin N; AGO -Austria, Innsbruck, Austria; Kliniken Essen Mitte (KEM), Essen, Germany; Medical University of Innsbruck, Innsbruck, Austria., O'Donnell D; Cancer Trials Ireland (CTI), Dublin, Ireland; St James's Hospital, Dublin, Ireland., Rauh-Hain A; Global Gynecologic Oncology Consortium (G-GOC), Houston, TX, USA; MD Anderson Cancer Center, The University of Texas, Houston, TX, USA., Herrington CS; Scottish Gynaecological Cancer Trials Group (SGCTG), Cancer Research UK, Edinburgh, UK; Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK., Marth C; AGO -Austria, Innsbruck, Austria; Medical University of Innsbruck, Innsbruck, Austria., Poveda A; Grupo Español de Cáncer de Ovario (GEICO), Madrid, Spain; Hospital Quironsalud, Valencia, Spain., Fujiwara K; Gynecologic Cancer Clinical Trials and Investigation Consortium (GOTIC), North Kanto, Japan; Saitama Medical University International Medical Center, Saitama, Japan., Stuart GCE; Canadian Cancer Trials Group (CCTG), Kingston, ON, Canada; University of British Columbia, Vancouver, BC, Canada., Oza AM; Princess Margaret Hospital Consortium (PMHC), Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Bookman MA; Gynecologic Oncology Group-Foundation (GOG-F), Philadelphia, PA, USA; San Francisco Medical Center, San Francisco, CA, USA.
Publikováno v: The Lancet. Oncology [Lancet Oncol] 2022 Aug; Vol. 23 (8), pp. e374-e384.
Zobrazit plný text záznamu
3
Roadmap for the European Network of Gynaecological Trial groups (ENGOT) Trials
Autor: Vergote, I., Elser, G., Votan, B., Farrelly, L., Roover, J. De, Bryce, J., Bois, A. du, Penninckx, B., Campo, J. Del, Pujade-Lauraine, E., Bamias, A., Calvert, P., Colombo, N., Pignata, S., Ledermann, J.A., Sehouli, J., Kristensen, G., Siddiqui, N., Tulunay, G., Pfisterer, J., Marth, C., Mirza, M., Ottevanger, P.B., Casado, A.
Publikováno v: International Journal of Gynecological Cancer, 23, 1339-43
International Journal of Gynecological Cancer, 23, 7, pp. 1339-43
The European Network for Gynaecological Oncological Trial groups (ENGOT) is a research network of the European Society of Gynaecological Oncology and was founded in Berlin in October 2007. Earlier, we reported on the ENGOT minimal requirements for tr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::503cd3f91f90d4ccb32c6ee08cd369ee
https://hdl.handle.net/2066/186688
Zobrazit plný text záznamu
4
Akademický článek
European Network of Gynaecological Oncological Trial Groups' requirements for trials between academic groups and industry partners - a new Model D for drug and medical device development.
Autor: Concin N; Department of Gynecology and Obstetrics, Medical University of Innsbruck, Innsbruck, Austria N.Concin@kem-med.com.; Department of Gynecology and Gynecological Oncology, Evangelische Kliniken Essen-Mitte, Essen, Germany., Ray-Coquard I; University Claude Bernard & Medical Oncology Centre Léon Bérard, GINECO group, Lyon, France., Glasspool RM; Department of Medical Oncology, Beatson West of Scotland Cancer Centre and University of Glasgow, Glasgow, UK., Braicu E; Department of Gynecology, Campus Virchow Klinikum, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Farrelly L; Cancer Research UK & University College London Cancer Trials Centre, London, UK., Votan B; ARCAGY-GINECO, Paris, France., Mirza MR; Department of Oncology, Rigshospitalet; Copenhagen University Hospital, Copenhagen, Denmark., Gonzalez Martin A; Department of Medical Oncology, Clinica Universidad de Navarra, Madrid, Madrid, Spain., Vergote I; Department of Gynecology and Obstetrics, Gynecologic Oncology, Leuven Cancer Institute, Catholic University Leuven, Leuven, Belgium., Pignata S; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Napoli, Naples, Italy.
Publikováno v: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2020 Jun; Vol. 30 (6), pp. 730-734. Date of Electronic Publication: 2020 May 12.
Zobrazit plný text záznamu
5
Akademický článek
[Clinical research activity of the French cancer cooperative network: Overview and perspectives].
Autor: Dubois C; Groupes coopérateurs en oncologie (GCO), 10, rue de la Grange-Batelière, 75009 Paris, France; Intergroupe francophone en cancérologie thoracique (IFCT), 10, rue de la Grange-Batelière, 75009 Paris, France. Electronic address: claire.dubois@ifct.fr., Morin F; Groupes coopérateurs en oncologie (GCO), 10, rue de la Grange-Batelière, 75009 Paris, France; Intergroupe francophone en cancérologie thoracique (IFCT), 10, rue de la Grange-Batelière, 75009 Paris, France., Moro-Sibilot D; Intergroupe francophone en cancérologie thoracique (IFCT), 10, rue de la Grange-Batelière, 75009 Paris, France., Langlais A; Intergroupe francophone en cancérologie thoracique (IFCT), 10, rue de la Grange-Batelière, 75009 Paris, France., Seitz JF; Fédération francophone de cancérologie digestive (FFCD), 7, boulevard Jeanne-d'Arc, 21000 Dijon, France., Girault C; Fédération francophone de cancérologie digestive (FFCD), 7, boulevard Jeanne-d'Arc, 21000 Dijon, France., Salles G; Centre hospitalier Lyon sud, service d'hématologie, bâtiment 1F, 69495 Pierre-Bénite, France., Haioun C; Centre hospitalier Lyon sud, service d'hématologie, bâtiment 1F, 69495 Pierre-Bénite, France., Deschaseaux P; The lymphoma academic research organisation (LYSARC), centre hospitalier Lyon sud, secteur Sainte-Eugénie, pavillon 6E, 69495 Pierre-Bénite, France., Casassus P; Intergroupe francophone du myélome (IFM), 8, rue de Parme, 75009 Paris, France., Mathiot C; Intergroupe francophone du myélome (IFM), 8, rue de Parme, 75009 Paris, France., Pujade-Lauraine É; Association de recherche sur les cancers dont gynécologiques-groupe d'investigateurs nationaux dans les études des cancers de l'ovaire et du sein (ARCAGY-GINECO), hôpital Hôtel-Dieu, B2, 5(e) étage, 1, parvis Notre-Dame, place Jean-Paul II, 75004 Paris, France., Votan B; Association de recherche sur les cancers dont gynécologiques-groupe d'investigateurs nationaux dans les études des cancers de l'ovaire et du sein (ARCAGY-GINECO), hôpital Hôtel-Dieu, B2, 5(e) étage, 1, parvis Notre-Dame, place Jean-Paul II, 75004 Paris, France., Louvet C; Groupe cooperateur multidisciplinaire en oncologie (GERCOR), 151, rue du Faubourg-Saint-Antoine, 75011 Paris, France., Delpeut C; Groupe cooperateur multidisciplinaire en oncologie (GERCOR), 151, rue du Faubourg-Saint-Antoine, 75011 Paris, France., Bardet É; CHU de Bretonneau, Groupe d'oncologie radiothérapie tête et cou (GORTEC), 2, boulevard Tonnellé, 33044 Tours, France., Vintonenko N; CHU de Bretonneau, Groupe d'oncologie radiothérapie tête et cou (GORTEC), 2, boulevard Tonnellé, 33044 Tours, France., Hoang Xuan K; Intergroupe coopérateur de neuro-oncologie-association des neuro-oncologues d'expression française (IGCNO-ANOCEF), 27, rue du Desous-des-Berges, 75013 Paris, France., Vo M; Intergroupe coopérateur de neuro-oncologie-association des neuro-oncologues d'expression française (IGCNO-ANOCEF), 27, rue du Desous-des-Berges, 75013 Paris, France., Michon J; Société française de lutte contre les cancers et les leucémies de l'enfant et de l'adolescent (SFCE), hôpital Trousseau, Sce d'anatomie et cytologie pathologique, 26, rue du Dr-Netter, 75012 Paris, France., Milleron B; Groupes coopérateurs en oncologie (GCO), 10, rue de la Grange-Batelière, 75009 Paris, France; Intergroupe francophone en cancérologie thoracique (IFCT), 10, rue de la Grange-Batelière, 75009 Paris, France.
Publikováno v: Bulletin du cancer [Bull Cancer] 2017 Jul - Aug; Vol. 104 (7-8), pp. 652-661. Date of Electronic Publication: 2017 Jul 05.
Zobrazit plný text záznamu
6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
7
Akademický článek
A Randomized Study of Ondansetron Syrup in Children: Evaluation of Taste Acceptability and Tolerance.
Autor: Stevens, R., Votan, B., Lane, R., Schaison, G.
Publikováno v: Pediatric Hematology & Oncology; 1996, Vol. 13 Issue 2, p199-202, 4p
Zobrazit plný text záznamu
9
Akademický článek
The efficacy of a combination of ondansetron, methylprednisolone and metopimazine in patients previously uncontrolled with a dual antiemetic treatment in cisplatin-based chemotherapy. The French Ondansetron Study Group.
Autor: Lebeau B; Hôpital Saint-Antoine, Paris, France., Depierre A, Giovannini M, Rivière A, Kaluzinski L, Votan B, Hédouin M, d'Allens H
Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 1997 Sep; Vol. 8 (9), pp. 887-92.
Zobrazit plný text záznamu
10
Akademický článek
[Value of the combination of oral ondansetron with methylprednisolone as soon as the first cure in mild emetogenic chemotherapy. Groupe français d'étude de l'ondansétron].
Autor: Coiffier B; Centre hospitalier Lyon-Sud, Pierre-Bénite, France., Khayat D, Misset JL, Votan B
Publikováno v: Bulletin du cancer [Bull Cancer] 1997 Aug; Vol. 84 (8), pp. 781-7.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje